Because CYP4Z1 and pseudogene CYP4Z2P were not expressed in RCC 19, we assumed that Six2 might promote the stemness of RCC cells via directly binding to the sox2 SRR2 enhancer region. This evidence concerns the gene SIX2 and renal cell carcinoma.